Pacira BioSciences Inc (PCRX): Next-Year EPS Estimate 25.62%
As of 2026-06-11, Pacira BioSciences Inc (PCRX) has a next-year EPS growth estimate of 25.62%.
On 2026-05-19, analyst consensus for PCRX's next-year EPS growth shifted from 25.64% to 25.62% — a negative change of 0.02 percentage points. The revised estimate has been sustained across 18 subsequent trading sessions. Current-year growth is projected at 8.53%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- EPS growth next year
- 25.62%
- EPS growth this year
- 8.53%
- EPS next quarter (est)
- $0.65
- Last price
- $23.36
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 25.62% | 8.53% | $0.65 | $23.36 |
| 2026-06-10 | 25.62% | 8.53% | $0.65 | $23.42 |
| 2026-06-09 | 25.62% | 8.53% | $0.65 | $23.21 |
| 2026-06-08 | 25.62% | 8.53% | $0.65 | $22.86 |
| 2026-06-07 | 25.62% | 8.53% | $0.65 | $22.75 |
| 2026-06-04 | 25.62% | 8.53% | $0.65 | $22.67 |
| 2026-06-03 | 25.62% | 8.53% | $0.65 | $22.32 |
| 2026-06-02 | 25.62% | 8.53% | $0.65 | $22.25 |
| 2026-06-01 | 25.62% | 8.53% | $0.65 | $22.96 |
| 2026-05-31 | 25.62% | 8.53% | $0.65 | $23.22 |
| 2026-05-28 | 25.62% | 8.53% | $0.65 | $23.68 |
| 2026-05-27 | 25.62% | 8.53% | $0.65 | $24.04 |
| 2026-05-26 | 25.62% | 8.53% | $0.65 | $24.36 |
| 2026-05-25 | 25.62% | 8.53% | $0.65 | $23.35 |
| 2026-05-24 | 25.62% | 8.53% | $0.65 | $23.35 |
| 2026-05-21 | 25.62% | 8.53% | $0.65 | $23.48 |
| 2026-05-20 | 25.62% | 8.53% | $0.65 | $23.00 |
| 2026-05-19 | 25.62% | 8.53% | $0.65 | $22.31 |
| 2026-05-18 | 25.64% | 8.51% | $0.65 | $22.44 |
| 2026-05-17 | 25.44% | 7.86% | $0.66 | $22.64 |
| 2026-05-14 | 25.44% | 7.86% | $0.66 | $23.53 |
| 2026-05-13 | 25.48% | 7.49% | $0.66 | $22.98 |
| 2026-05-12 | 25.48% | 7.49% | $0.66 | $22.84 |
| 2026-05-11 | 25.48% | 7.49% | $0.66 | $22.74 |
| 2026-05-10 | 25.48% | 7.49% | $0.66 | $23.15 |
| 2026-05-07 | 25.48% | 7.49% | $0.66 | $23.64 |
| 2026-05-06 | 25.48% | 7.49% | $0.66 | $23.69 |
| 2026-05-05 | 25.48% | 7.49% | $0.66 | $24.79 |
| 2026-05-04 | 25.48% | 7.49% | $0.66 | $24.69 |
| 2026-05-03 | 25.48% | 7.49% | $0.66 | $24.44 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Pacira BioSciences Inc's next-year EPS growth estimate?▾
As of 2026-06-11, Pacira BioSciences Inc (PCRX) has a next-year EPS growth estimate of 25.62%, based on analyst consensus.
When was the latest EPS estimate revision for PCRX?▾
The most recent revision occurred on 2026-05-19, when analysts adjusted the next-year EPS growth estimate from 25.64% to 25.62%.
What sector and industry does Pacira BioSciences Inc belong to?▾
Pacira BioSciences Inc operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. PCRX appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Pacira BioSciences Inc (PCRX) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports